Global Ramipril Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2022 –2029 |
 Market Size (Base Year) |
USD 550.00 Billion |
 Market Size (Forecast Year) |
USD 729.86 Billion |
 CAGR |
% |
| Major Markets Players |
>全球雷米普利市场，按产品类型（片剂、胶囊、溶液）、适应症（高血压、心力衰竭、糖尿病肾病等）、最终用户（医院、家庭护理、专科诊所等）、分销渠道（医院药房、网上药房、零售药房）划分 - 行业趋势和预测到 2029 年。
市场分析和见解
雷米普利是一种血管紧张素转换酶 (ACE) 抑制剂类药物。它通常用于治疗高血压和心力衰竭。它有胶囊、药丸和口服溶液等形式。它可以单独使用或与其他心血管药物联合使用。
药物配方的不断进步和 ACE 抑制剂在慢性疾病中的应用将有助于治疗高血压和心力衰竭。Data Bridge Market Research 分析称，雷米普利市场在 2021 年的价值为 5.5 亿美元，到 2029 年可能达到 7.2986 亿美元，预计在 2022 年至 2029 年的预测期内复合年增长率为 3.6%。
报告范围和市场细分
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020（可定制至 2019 - 2014） |
|
定量单位 |
收入（单位：十亿美元）、销量（单位：台）、定价（美元） |
|
涵盖的领域 |
产品类型（药片、胶囊、溶液）、适应症（高血压、心力衰竭、糖尿病肾病、其他）、最终用户（医院、家庭护理、专科诊所、其他）、分销渠道（医院药房、网上药房、零售药房） |
|
覆盖国家 |
美国、加拿大、墨西哥、秘鲁、巴西、阿根廷、南美洲其他地区、德国、意大利、英国、法国、西班牙、荷兰、比利时、瑞士、土耳其、俄罗斯、匈牙利、立陶宛、奥地利、爱尔兰、挪威、波兰、欧洲其他地区、日本、中国、印度、韩国、澳大利亚、新加坡、马来西亚、泰国、印度尼西亚、菲律宾、越南、亚太地区其他地区、南非、沙特阿拉伯、阿联酋、科威特、以色列、埃及、中东和非洲其他地区 |
|
涵盖的市场参与者 |
辉瑞公司（美国）、梯瓦制药工业有限公司（以色列）、鲁宾制药公司（印度）、Hikma Pharmaceuticals PLC（英国）、雷迪博士实验室有限公司（印度）、Zydus Cadila（印度）、Aurobindo Pharma Limited（印度）、Zentiva Group, as（捷克）、诺华公司（瑞士）、WOCKHARDT（印度）、Perrigo Company plc（爱尔兰）、赛诺菲（法国）、Brown & Burk.（英国）、Amneal Pharmaceuticals LLC（美国）、Arrow Precision Ltd.（英国）、Apotex（加拿大）、Micro Labs Ltd.（印度）、Cipla Inc.（美国）、Pharmanova limited（加纳）和 Opsonin Pharma Limited（孟加拉国） |
|
市场机会 |
|
雷米普利 市场动态
驱动程序：
Major factors that are expected to boost the growth of the ramipril market in the forecast period are as follows:
- Rise in the cardiovascular diseases
Growing cardiovascular diseases such as high blood pressure and hypertension is one of the contributing factors.
- Development in treatment
Advancement in the treatment including improvement in the formulation of the drug and growing adoption of ACE inhibitors for chronic disorders.
- Growing demand for less expensive drugs
Increase in the healthcare expenditure and rising need for better drugs is further estimated to cushion the growth of the ramipril market.
Opportunities
In addition, the rise in the research and development on the ramipril drug and advancing market regulations and financial donations from governing bodies will further provide potential opportunities for the growth of the ramipril market in the coming years.
Restraints/Challenges
On the other hand, the dangerous effects of the drugs such as rectum bleeding and stomach cramping is further projected to impede the growth of the ramipril market in the timeline period. However, the stringent regulation might further challenge the growth of the ramipril market in the near future.
This ramipril market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on ramipril market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Patient Epidemiology Analysis
The ramipril market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
COVID-19 Impact on Ramipril Market
COVID-19 has a significant impact on the ramipril market. Pharmaceutical and biotech businesses, in collaboration with governments around the world, are working to combat the COVID-19 outbreak, from vaccine development to pharmaceutical supply chain planning. Approximately 115 vaccine candidates and 155 compounds are currently being developed in the research and development pipeline. Furthermore, routinely used medications such as hydroxychloroquine have shown a huge increase in demand for COVID-19 treatment. Due to the enormous demand for these treatments, manufacturers of COVID-19 management drugs have a lot of prospects, due to COVID-19 vaccination and therapy medications are in high demand.
Recent Developments
- In 2020, the launch of ramipril for the treatment of COVID-19 (RAMIC), a placebo oral capsule for the treatment of heart failure and other cardiovascular diseases, was announced by Pfizer Inc., an American multinational pharmaceutical and biotechnology business.
- Cardiopril 5 Capsule was launched by Dr. Reddy's Laboratories, an Indian multinational pharmaceutical firm, in 2020 for the prevention of stroke, hypertension, and high blood pressure.
Global Ramipril Market
The ramipril market is segmented on the basis of product type, indication, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Tablets
- Capsules
- Solutions
On the basis of product type, the ramipril market is segmented into tablets, capsules and solutions.
Indication
- High Blood Pressure
- Heart Failure
- Diabetic Kidney Disease
- Others
On the basis of indication, the ramipril market is segmented into high blood pressure, heart failure, diabetic kidney disease and others.
End Users
- Hospitals
- Homecare
- Specialty Clinics
- Others
On the basis of end users, the global ramipril market is segmented into hospitals, homecare, specialty clinics and others.
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
On the basis of distribution channel, the ramipril market has been bifurcated into hospital pharmacy, online pharmacy and retail pharmacy.
Ramipril Market Regional Analysis/Insights
The ramipril market is analysed and market size insights and trends are provided by country, product type, indication, end users and distribution channel as referenced above.
雷米普利市场报告涉及的国家包括美国、加拿大、墨西哥、秘鲁、巴西、阿根廷、南美洲其他地区、德国、意大利、英国、法国、西班牙、荷兰、比利时、瑞士、土耳其、俄罗斯、匈牙利、立陶宛、奥地利、爱尔兰、挪威、波兰、欧洲其他地区、日本、中国、印度、韩国、澳大利亚、新加坡、马来西亚、泰国、印度尼西亚、菲律宾、越南、亚太其他地区、南非、沙特阿拉伯、阿联酋、科威特、以色列、埃及、中东和非洲其他地区。
由于政府采取了多项举措，北美在雷米普利市场占据主导地位。此外，在预测期内，用于改善心血管疾病治疗的资金不断增加将进一步促进该地区雷米普利市场的增长。
由于医疗设施的不断进步，亚太地区雷米普利市场预计将出现大幅增长。此外，政府采取的举措也将在未来几年进一步推动该地区雷米普利市场的增长。
报告的国家部分还提供了影响单个市场因素和国内市场法规变化，这些变化影响了市场的当前和未来趋势。新销售、替代销售、国家人口统计、疾病流行病学和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、销售渠道的影响。
竞争格局和雷米普利 市场份额分析
雷米普利市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对雷米普利市场的关注有关。
雷米普利市场的一些主要参与者包括
- 辉瑞公司（美国）
- Teva Pharmaceutical Industries Ltd.（以色列）
- Lupin Pharmaceuticals, Inc.（印度）
- Hikma Pharmaceuticals PLC（英国）
- Dr. Reddy's Laboratories Ltd（印度）
- Zydus Cadila（印度）
- Aurobindo Pharma Limited（印度）
- Zentiva Group, as（捷克）
- 诺华公司（瑞士）
- WOCKHARDT（印度）
- Perrigo Company plc（爱尔兰）
- 赛诺菲（法国）
- Brown & Burk.（英国）
- Amneal Pharmaceuticals LLC（美国）
- Arrow Precision Ltd.（英国）
- Apotex（加拿大）
- Micro Labs Ltd.（印度）
- Cipla Inc.（美国）
- Pharmanova 有限公司（加纳）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
